Graves Light Lenhart Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-592
Closed -$50K 440
2022
Q2
$50K Sell
592
-60
-9% -$5.26K 0.01% 305
2022
Q1
$57K Sell
652
-1,302
-67% -$113K 0.01% 342
2021
Q4
$171K Buy
1,954
+110
+6% +$9.13K 0.02% 208
2021
Q3
$151K Buy
1,844
+68
+4% +$6.12K 0.02% 208
2021
Q2
$162K Buy
1,776
+140
+9% +$12.5K 0.03% 197
2021
Q1
$140K Sell
1,636
-42
-3% -$3.77K 0.02% 217
2020
Q4
$158K Buy
+1,678
New +$147K 0.03% 194

Other funds holding NVS

Graves Light Lenhart Wealth's NVS Position: Q3 2022 in Review

Graves Light Lenhart Wealth sold out of Novartis (NVS) in Q3 2022, closing a stake of 592 shares — an estimated $50K sold.

Graves Light Lenhart Wealth first reported a position in NVS in Q4 2020 and held it in 7 quarters. The position peaked at $171K in Q4 2021. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • Graves Light Lenhart Wealth reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 592 Novartis shares in Q3 2022, an estimated $50K.
  • Graves Light Lenhart Wealth first reported a position in Novartis in Q4 2020 and held it in 7 quarters.
  • Graves Light Lenhart Wealth's Novartis position peaked at $171K in Q4 2021.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.